Literature DB >> 1994422

Combined gadolinium-enhanced and fat-saturation MR imaging of renal masses.

R C Semelka1, H Hricak, S K Stevens, R Finegold, E Tomei, P R Carroll.   

Abstract

Combined gadopentetate dimeglumine enhancement and fat-saturation (FS) spin-echo (SE) magnetic resonance (MR) imaging for the detection and characterization of renal masses was evaluated in 43 patients with a total of 71 lesions (28 solid masses and 43 cysts). SE MR sequences compared were the following: short repetition time (TR)/echo time (TE), conventional SE, short TR/TE FS SE, long TR/TE conventional SE, gadolinium-enhanced short TR/TE conventional SE, and gadolinium-enhanced short TR/TE FS SE techniques. MR findings were compared with findings of contrast-enhanced computed tomography (CT) and with pathologic findings in all patients. The sensitivities for detection of renal masses with gadolinium-enhanced FS (71 of 71 lesions) and with gadolinium-enhanced short TR/TE conventional (65 of 71 lesions) SE sequences were significantly (P less than .01) greater than with any unenhanced (short TR/TE conventional [40 of 71 lesions], or long TR/TE [39 of 71 lesions]) SE sequence. Lesion characterization was also best with the gadolinium-enhanced FS SE sequence (65 of 71 lesions correctly classified). When combined pre- and postcontrast short TR/TE FS SE images were analyzed with both qualitative (visual) and quantitative (region-of-interest measurements) assessment, lesion characterization improved even further (70 of 71 lesions were correctly characterized). All lesions detected with CT were visualized with the gadolinium-enhanced FS SE MR sequence, which in addition depicted seven cysts and two small renal cell carcinomas. In summary, the use of gadopentetate dimeglumine, especially when combined with the FS technique, was superior to unenhanced MR imaging for detection and characterization of renal lesions.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1994422     DOI: 10.1148/radiology.178.3.1994422

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  15 in total

1.  Progressing Toward a Cohesive Pediatric 18F-FDG PET/MR Protocol: Is Administration of Gadolinium Chelates Necessary?

Authors:  Christopher Klenk; Rakhee Gawande; Vy Thao Tran; Jennifer Trinh Leung; Kevin Chi; Daniel Owen; Sandra Luna-Fineman; Kathleen M Sakamoto; Alex McMillan; Andy Quon; Heike E Daldrup-Link
Journal:  J Nucl Med       Date:  2015-10-15       Impact factor: 10.057

2.  MR classification of renal masses with pathologic correlation.

Authors:  Ivan Pedrosa; Mary T Chou; Long Ngo; Ronaldo H Baroni; Elizabeth M Genega; Laura Galaburda; William C DeWolf; Neil M Rofsky
Journal:  Eur Radiol       Date:  2007-09-26       Impact factor: 5.315

3.  The Role of Apparent Diffusion Coefficient Quantification in Differentiating Benign and Malignant Renal Masses by 3 Tesla Magnetic Resonance Imaging.

Authors:  Cemil Göya; Cihad Hamidi; Yaşar Bozkurt; Alpaslan Yavuz; Suzan Kuday; Hatice Gümüş; Gül Türkçü; Salih Hattapoğlu; Aslan Bilici
Journal:  Balkan Med J       Date:  2015-07-01       Impact factor: 2.021

4.  Transitional cell carcinoma of the upper urinary tract: staging by MRI.

Authors:  S M Weeks; E D Brown; J J Brown; M K Adamis; L B Eisenberg; R C Semelka
Journal:  Abdom Imaging       Date:  1995 Jul-Aug

5.  Prognostic implications of the magnetic resonance imaging appearance in papillary renal cell carcinoma.

Authors:  Andrew B Rosenkrantz; Aarti Sekhar; Elizabeth M Genega; Jonathan Melamed; James S Babb; Amish D Patel; Andy Lo; Robert M Najarian; Muneeb Ahmed; Ivan Pedrosa
Journal:  Eur Radiol       Date:  2012-08-21       Impact factor: 5.315

6.  Liver lesion detection: comparison between excitation-spoiling fat suppression and regular spin-echo at 1.5T.

Authors:  R C Semelka; H Hricak; K G Bis; W C Werthmuller; C B Higgins
Journal:  Abdom Imaging       Date:  1993

7.  Bile duct disease: prospective comparison of ERCP, CT, and fat suppression MRI.

Authors:  R C Semelka; J P Shoenut; M A Kroeker; H Hricak; G Y Minuk; C S Yaffe; A B Micflikier
Journal:  Gastrointest Radiol       Date:  1992

8.  Comparison of 1.0 M gadobutrol and 0.5 M gadopentate dimeglumine-enhanced MRI in 471 patients with known or suspected renal lesions: results of a multicenter, single-blind, interindividual, randomized clinical phase III trial.

Authors:  Bernd Tombach; Klaus Bohndorf; Wolfgang Brodtrager; Claus D Claussen; Christoph Düber; Michael Galanski; Eckhardt Grabbe; Giacomo Gortenuti; Michael Kuhn; Walter Gross-Fengels; Renate Hammerstingl; Brigitte Happel; Gertraud Heinz-Peer; Gregor Jung; Thomas Kittner; Roberto Lagalla; Philipp Lengsfeld; Reinhard Loose; Raymond H G Oyen; Pietro Pavlica; Christiane Pering; Roberto Pozzi-Mucelli; Thorsten Persigehl; Peter Reimer; Nomdo S Renken; Götz M Richter; Ernst J Rummeny; Fritz Schäfer; Malgorzata Szczerbo-Trojanowska; Andrzej Urbanik; Thomas J Vogl; Paul Hajek
Journal:  Eur Radiol       Date:  2008-07-08       Impact factor: 5.315

Review 9.  Imaging in the staging of renal cell carcinoma.

Authors:  R H Reznek
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

10.  Contrast enhancement of the gastrointestinal tract on MR images using intravenous gadolinium-DTPA.

Authors:  S A Mirowitz
Journal:  Abdom Imaging       Date:  1993
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.